Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.

A Archinal-Mattheis(Sanden (Japan)), Dalia Cohen(Regulus Therapeutics (United States)), Yoshie Itoh, Noriko Kokubu, Kenneth W. Bair(Novartis (United States)), Toru Watanabe(Yamagata University), Nicholas J. Combates(Sanden (Japan)), Rafał Rzepka
PubMed
January 1, 1995
Cited by 62


Related Papers